PGNX
Knobias Clip Report (10-15-2007)
Tuesday, October 16th, 2007Rating 3.00 out of 5
[?]Sumbmited From Knobias ClipReport
PGNX: To Begin Ph II Trial of Oral Methylnaltrexone in Opioid Constipation
Progenics Pharmaceuticals, Inc. (PGNX) got a modest boost at Monday’s open after announcing plans with Wyeth (WYE) to begin two Phase 2 clinical trials to evaluate daily dosing of oral methylnaltrexone in patients with chronic, non-malignant pain […]
